While the role of ERBB3 mutation in cancer progression and therapeutic resistance has been previously studied13,14, KRAS15,16, KDR17, and ATR18,19 mutations and the GOPC-ROS120,21 fusion gene have also been widely studied to determine their functions in cancer biology. This evidence concerns the gene ERBB3 and cancer.